The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID‐19: A meta‐analysis of randomized trials

BACKGROUND: Overactivation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome can lead to severe illness in patients with coronavirus disease‐2019 (COVID‐19). The NLRP3 inhibitor, colchicine, therefore, appears to be promising for the treatment of COVID‐19. AIMS: We aimed to perform a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kow, Chia Siang, Lee, Learn‐Han, Ramachandram, Dinesh Sangarran, Hasan, Syed Shahzad, Ming, Long Chiau, Goh, Hui Poh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767506/
https://www.ncbi.nlm.nih.gov/pubmed/34970856
http://dx.doi.org/10.1002/iid3.562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767506/
https://www.ncbi.nlm.nih.gov/pubmed/34970856
http://dx.doi.org/10.1002/iid3.562

Ejemplares similares